ITMAT in the News
Tuesday, July 26, 2016
A new appreciation for the interplay between two cell nucleus proteins that lead both intertwined and separate lives is helping researchers better understand fatty liver disease, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania.
Monday, July 18, 2016
Penn Medicine has established the Penn Neurodegeneration Genomics Center (PNGC) as a national focal point for Alzheimer's disease (AD) genetics research.
Thursday, July 14, 2016
Researchers from the Perelman School of Medicine at the University of Pennsylvania have now identified a unique subset of tumor associated neutrophils that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
Wednesday, July 13, 2016
A receptor protein that is the target of the breast cancer drug trastuzumab (Herceptin) is needed for proper heart blood-vessel development, reported researchers from the Perelman School of Medicine at the University of Pennsylvania.
Penn Medicine to Develop the Next Generation of Viral Vectors -- called AAV 3.0™ -- for Gene Therapies and Genome Editing
Wednesday, June 29, 2016
The Perelman School of Medicine at the University of Pennsylvania has launched a new program, called AAV 3.0™, to create new viral vectors to find quicker and better treatments for an array of diseases.
Wednesday, June 8, 2016
Evidence of DNA "scrunching" may one day lead to a new class of drugs against viruses, according to a research team from the Perelman School of Medicine at the University of Pennsylvania, the Georgia Institute of Technology, and Columbia University.
Monday, June 6, 2016
Researchers from the Perelman School of Medicine at the University of Pennsylvania have figured out how to make a much-improved research tool that they hope will open the door to new and better HIV vaccine designs.
Thursday, June 2, 2016
In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system.
Friday, May 27, 2016
A benign virus normally found in the skin can lead to a type of rare, lethal skin cancer. Specifically, infection by the Merkel cell polyomavirus can lead to Merkel cell carcinoma in immune-compromised individuals. Researchers have now identified a type of skin cell as the target of the virus in humans.
Rhythm of "Detox" and Feeding Genes in Fruitflies and Mice Coordinated by Neuropeptide, According to Penn Study
Tuesday, May 17, 2016
A 24-hour rhythm of cellular detoxification in flies and mammals is coordinated by a neuropeptide that also drives feeding in both organisms, found a team led by Amita Sehgal, PhD, a professor of Neuroscience and director of the Chronobiology Program, in the Perelman School of Medicine at the University of Pennsylvania.